Johnson & Johnson (NYSE:JNJ) recently announced that its Biosense Webster business has secured FDA approval for its Thermocool SmartTouch SF ablation catheter.
The Thermocool SmartTouch received approval for the treatment of persistent atrial fibrillation, J&J announced yesterday.
Get the full story on our sister site Medical Tubing + Extrusion.